The piping systems and water systems are made to carry vital services like PW, WFI, pure steam, process gases and CIP solutions without compromising product quality or microbial safety. However, even the most efficient water systems can present a risk of contamination when stagnant regions inside the piping system appear. The presence of dead legs is one of the main culprits responsible for microbial contamination in pharmaceutical water systems.
During the inspections by health authorities, dead legs are frequently found because they create ideal conditions for the emergence of microbiological life, biofilm formation and other harmful pollutants. Once biofilm is formed in dead legs, it becomes practically impossible to eliminate it and sanitation measures may prove to be useless.
From my experience, the emergence of dead legs happens at the design stage rather than at the production facility. The occurrence of dead legs is often the product of poor design, unnecessary iterations and repositioning of piping systems as a result of plant modernization. Luckily, careful design and proper handling of any changes can help remove the opportunity for dead legs to appear in the first place, avoiding any issues with product quality.
During the installation process, dead leg occurrence does not seem to be an important issue; still, this segment can cause microbiological issues in a pharmaceutical utility system at some point in time.
Dead legs are often found in:
They include:
Most of the time, regulations do not specify all the requirements related to engineering but they ask for the systems that should be designed to be cleaned, drained and meet microbiological requirements.
Example:
Internal diameter of the main pipe: 25 mm
Maximum length of the branch: 75 mm
It is crucial to follow the ratio since any other length may not have sufficient flow of liquid during the normal circulation process. Though 3D Rule is regarded to be a good engineering principle, the use of engineering intuition is still requisite.
When it comes to pharmaceutical pipe systems, dead legs continue to be among the sources of contamination that can be avoided. They may be viewed as insignificant engineering features, but in reality, dead legs can have a serious effect on microbial control, water quality and regulatory compliance. It is important to know that proper dead leg management starts at the design stage, continues with installation and validation and is an important part of long-term maintenance.
From my experience, the best pharmaceutical water systems are those systems designed with the principles of simplicity, continuous circulation and hygiene engineering modern concepts. By involving sound piping design, change control measures, regular inspections and etc., the manufacturers can significantly reduce microbiological risks, maintain their water systems in working order indefinitely, as well as ensure compliance with the requirements of GMP all over the world.
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/high-purity-water-system-793
2. USP General Chapter <1231> Water for Pharmaceutical Purposes
https://www.usp.org
During the inspections by health authorities, dead legs are frequently found because they create ideal conditions for the emergence of microbiological life, biofilm formation and other harmful pollutants. Once biofilm is formed in dead legs, it becomes practically impossible to eliminate it and sanitation measures may prove to be useless.
From my experience, the emergence of dead legs happens at the design stage rather than at the production facility. The occurrence of dead legs is often the product of poor design, unnecessary iterations and repositioning of piping systems as a result of plant modernization. Luckily, careful design and proper handling of any changes can help remove the opportunity for dead legs to appear in the first place, avoiding any issues with product quality.
Understanding Dead Legs
The term "dead leg" refers to a segment of pipe wherein there is practically no fluid flow in the normal operation of the system. These stagnant sections can result in microorganisms replicating and forming biofilms on the internal piping surfaces since they have enough time to thrive in stagnant water or process fluid remaining in these dead leg sections.During the installation process, dead leg occurrence does not seem to be an important issue; still, this segment can cause microbiological issues in a pharmaceutical utility system at some point in time.
Dead legs are often found in:
- Unused connections of branches
- Isolated sampling ports
- Spare connections of devices
- Rarely appliances
- Solution lines for future expansion
- Sections of sealing pipe
- Closed bypasses
Why Dead Legs are a Major GMP Concern
The goal of pharmaceutical water systems is to keep the water moving since motion helps inhibit bacteria. If water has stopped flowing in a portion of pipes certain unfavorable conditions appear.They include:
- The water being stagnant
- A decrease in the efficiency of sanitization
- The formation of biofilms
- The appearance of bacteria
- The accumulation of particles
- The rise of endotoxins levels
- The difficulty in cleaning
Regulatory Considerations
Regulatory authorities around the world require pharmaceutical companies to develop piping arrangements that will avoid areas where standing water might accumulate. During inspections, the regulatory authorities look at documents like:- Piping and Instrumentation Diagram (P&ID)
- Isometric drawings
- Water system qualification documents
- Maintenance information
- Sanitization protocols
- Microbial trend reports
- Engineering modifications documentation
Most of the time, regulations do not specify all the requirements related to engineering but they ask for the systems that should be designed to be cleaned, drained and meet microbiological requirements.
The 3D Rule
One of the most acknowledged principles of engineering to avoid the dead legs is the 3D Rule. It is about the length of the branch connection must not be more than three times the internal diameter of the main pipe.Example:
Internal diameter of the main pipe: 25 mm
Maximum length of the branch: 75 mm
It is crucial to follow the ratio since any other length may not have sufficient flow of liquid during the normal circulation process. Though 3D Rule is regarded to be a good engineering principle, the use of engineering intuition is still requisite.
Common Causes of Dead Legs
Dead legs are often caused by slow changes in the design of a facility as it grows and changes. The most common causes include:1. Poor Initial Design
The routing of pipes during construction of a facility can sometimes lead to unnecessary dead legs. Some examples of things that create dead legs include:- Manifolds that are too large
- Pipes that are too long
- Pipes that do not lead anywhere
- Bad placement of valves
2. Facility Expansion
Many pharmaceutical plants have unused pipe locations installed for growth. Unfortunately, these connections are not always used for years. Without flushing processes, they provide a perfect environment for bacteria.3. Improper Valve Installation
Using a valve in the wrong position can create dead spots in the pipes. Even sanitary valves can cause dead legs if used improperly. Valves should be positioned in such a way that they aid in drainage and flow.4. Rarely Used Sampling Locations
Sampling valves that are not utilized for long periods of time can often develop localized dead legs. Regular flushing as well as preventive maintenance should be included as part of standard practices.Engineering Solutions to Avoid Dead Legs
A good dead leg management plan commences in the design phase and continues throughout the facility's lifecycle.1. Design for Continuous Flow
Constant flow is key for avoiding biological contamination. Engineers should develop piping loops with the following characteristics:- Even flow velocity
- Low-pressure drop
- Full circulation
- Good temperature control
2. Minimize Unused Connections
Each additional branch raises the risk of contamination. As opposed to adding various spare connections, do that only when there are plans for expansion. Otherwise, empty connections should be removed whenever it is possible.3. Install Hygienic Valves
The sanitary diaphragm valves are better compared to traditional valves and allow the limiting of the places in the valve where the fluid can dwell. It is important to pay attention to:- Cleanability
- Draining
- Surface finish
- Maintenance requirements
4. Optimize Instrument Connections
Install pressure gauges, conductivity meters, temperature sensors, flow meters using hygienic connections. Avoid long instrument tees as much as possible.Material Selection and Surface Finish
Even with optimal pipe design, the use of wrong materials may lead to contamination. Water systems in the pharmaceutical industry usually implement electropolished 316L stainless steel, which provides means:- Good corrosion resistance
- Smooth surface inside the pipe
- Reduced ability of biofilms to develop on the surface of the pipes
- Better cleanability of the pipe system
Validation Following Piping Modifications
Every time the changes are made in the pipe network, the manufacturers should find out if it is necessary to qualify again. The process of validation can include:- Inspections conducted by engineers
- Boroscope inspection if necessary
- Review of the documentation regarding welding
- Verification of passivation
- Pressure test
- Verification of the flow
- Water treatment
- Control over the quality of water
- Microbiological testing
Monitoring for Hidden Dead Legs
Systems that are designed properly still need to be reviewed regularly. There are signs of dead legs that can be identified:- Repeated issues with microbes
- Local failures in endotoxin
- Delayed recovery of sanitization
- High total organic carbon (TOC)
- Continued contamination at certain sampling points
- Increases in microorganisms during certain times of the year
Managing Dead Legs Through Change Control
It is important to follow the formal change control process for every piping alteration that takes place. The engineering assessment must consider:- Possibility of formation of stagnation regions
- Impact on the movement of water
- Influence on the qualification status
- Necessary validation requirements
- Updated maintenance methodologies
Common Mistakes
Many engineering mistakes can lead to the presence of dead legs, including:- Installation of extra pipes for future expansion with no clear purpose
- Disregard for the 3D rule when installing equipment
- Use of lengthy connecting branches for instruments
- Retention of unnecessary piping after removal of equipment
- Closing valves permanently without removing required pipes
- Lack of change control for pipes that are modified
- Failure to conduct necessary engineering evaluation of distribution pipes
Engineering Recommendations for Implementation
The following engineering practices are recommended for organizations aiming to improve the design of pharmaceutical pipelines:- Always review layout of pipes whenever there is a modification in the facility.
- Take out the unused pipes instead of leaving them behind.
- Keep the lengths of lateral connections used in sampling systems to a minimum.
- Ensure circulation is done continuously whenever possible.
- Use of hygienic fittings and valves.
- Conduct periodic engineering evaluation of the fluid distribution systems.
- Trend the results of microbiology to detect any local contamination.
- Make sure that piping evaluation forms a part of the yearly evaluation of pipe mapping.
- Re-qualify critical lines after modification.
- Educate engineering and maintenance personnel on hygienic design practices.
From my experience, the best pharmaceutical water systems are those systems designed with the principles of simplicity, continuous circulation and hygiene engineering modern concepts. By involving sound piping design, change control measures, regular inspections and etc., the manufacturers can significantly reduce microbiological risks, maintain their water systems in working order indefinitely, as well as ensure compliance with the requirements of GMP all over the world.
Regulatory References
1. FDA Guide to Inspections of High Purity Water Systemshttps://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/high-purity-water-system-793
2. USP General Chapter <1231> Water for Pharmaceutical Purposes
https://www.usp.org

No comments:
Post a Comment
Please don't spam. Comments having links would not be published.